PuSH - Publication Server of Helmholtz Zentrum München

Mazur, P.K.* ; Einwächter, H.* ; Lee, M.* ; Sipos, B.* ; Nakhai, H.* ; Rad, R.* ; Zimber-Strobl, U. ; Strobl, L.J. ; Radtke, F.* ; Klöppel, G.* ; Schmid, R.M.* ; Siveke, J.T.*

Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma.

Proc. Natl. Acad. Sci. U.S.A. 107, 13438-13443 (2010)
DOI PMC
Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
Pancreatic cancer is one of the most fatal malignancies lacking effective therapies. Notch signaling is a key regulator of cell fate specification and pancreatic cancer development; however, the role of individual Notch receptors and downstream signaling is largely unknown. Here, we show that Notch2 is predominantly expressed in ductal cells and pancreatic intraepithelial neoplasia (PanIN) lesions. Using genetically engineered mice, we demonstrate the effect of conditional Notch receptor ablation in KrasG12D-driven pancreatic carcinogenesis. Deficiency of Notch2 but not Notch1 stops PanIN progression, prolongs survival, and leads to a phenotypical switch toward anaplastic pancreatic cancer with epithelial-mesenchymal transition. By expression profiling, we identified increased Myc signaling regulated by Notch2 during tumor development, placing Notch2 as a central regulator of PanIN progression and malignant transformation. Our study supports the concept of distinctive roles of individual Notch receptors in cancer development.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9.432
3.610
109
165
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Genetically engineered mice; K-Ras; Myc; Notch; Pancreatic cancer
Language english
Publication Year 2010
HGF-reported in Year 2010
ISSN (print) / ISBN 0027-8424
e-ISSN 1091-6490
Quellenangaben Volume: 107, Issue: 30, Pages: 13438-13443 Article Number: , Supplement: ,
Publisher National Academy of Sciences
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-501500-003
PubMed ID 20624967
Scopus ID 77955827414
Erfassungsdatum 2010-11-16